News KALA BIO, Inc. BOERSE MUENCHEN

Equities

27F0

US4831192020

Market Closed - BOERSE MUENCHEN Other stock markets 03:44:21 2024-07-08 pm EDT			5-day change	1st Jan Change
6.45 ^EUR	+0.62%		-4.33%	-4.90%

Jun. 28	KALA BIO, Inc. announced that it has received $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP	CI
Jun. 27	Top Midday Gainers	MT

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

KALA BIO, Inc. announced that it has received $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP	Jun. 27	CI
Top Midday Gainers	Jun. 27	MT
Sector Update: Health Care Stocks Mixed Premarket Thursday	Jun. 27	MT
Kala Bio to Raise $12.5 Million in Private Placement; Shares Jump	Jun. 27	MT
KALA BIO Announces $12,500,000 Private Placement	Jun. 27	AQ
KALA BIO, Inc. announced that it expects to receive $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP	Jun. 25	CI
KALA BIO : Corporate Overview - June 2024	Jun. 05	PU
KALA BIO to Present at Jefferies Global Healthcare Conference	May. 29	AQ
HC Wainwright Adjusts Kala Pharmaceuticals Price Target to $18 From $21, Maintains Buy Rating	May. 17	MT
KALA BIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update	May. 14	AQ
HC Wainwright Trims KALA BIO's Price Target to $21 From $22, Keeps Buy Rating	Apr. 02	MT
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Apr. 01	AQ
KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
KALA BIO, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 29	CI
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Mar. 29	AQ
KALA BIO, Inc. announced that it expects to receive $8.599799 million in funding from Baker Bros. Advisors LP	Mar. 24	CI
North American Morning Briefing : Stocks Struggle After New Records	Mar. 22	DJ
North American Morning Briefing : Inflation -2-	Mar. 15	DJ
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference	Feb. 26	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News KALA BIO, Inc. BOERSE MUENCHEN

Equities

27F0

US4831192020

Summary

Filters